v3.26.1
Fair Value Measurements
6 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
Fair Value Measurements

4. Fair Value Measurements

 

ASC 820, Fair Value Measurement, the authoritative guidance on fair value measurements, establishes a framework with respect to measuring assets and liabilities at fair value on a recurring basis and non-recurring basis. Under the framework, fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as of the measurement date. The framework also establishes a three-tier hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability, and are developed based on the best information available in the circumstances. The hierarchy consists of the following three levels:

 

Level 1: Inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.

 

Level 2: Inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

 

Level 3: Inputs are unobservable inputs for the asset or liability.

 

The following tables present information about the Company’s financial assets measured at fair value on a recurring basis, based on the three-tier fair value hierarchy:

 

 

As of June 30, 2026

 

(in thousands)

Level 1

 

Level 2

 

Level 3

 

Total

 

Cash equivalents:

 

 

 

 

 

 

 

 

Money market funds

$

7,418

 

$

-

 

$

-

 

$

7,418

 

Total cash equivalents

$

7,418

 

$

-

 

$

-

 

$

7,418

 

Current marketable securities:

 

 

 

 

 

 

 

 

U.S. Treasury securities

$

-

 

$

1,996

 

$

-

 

$

1,996

 

Total current marketable securities

$

-

 

$

1,996

 

$

-

 

$

1,996

 

Total marketable securities and cash equivalents

$

7,418

 

$

1,996

 

$

-

 

$

9,414

 

Financial liabilities:

 

 

 

 

 

 

 

 

Loan Facility

$

-

 

$

-

 

$

46,659

 

$

46,659

 

Warrant liabilities

 

-

 

 

-

 

 

879

 

 

879

 

Non-qualified deferred compensation plan liability

 

-

 

 

4,433

 

 

-

 

 

4,433

 

Total financial liabilities

$

-

 

$

4,433

 

$

47,538

 

$

51,971

 

Financial assets:

 

 

 

 

 

 

 

 

Corporate-owned life insurance policies

$

-

 

$

3,208

 

$

-

 

$

3,208

 

Total financial assets

$

-

 

$

3,208

 

$

-

 

$

3,208

 

 

 

As of December 31, 2025

 

(in thousands)

Level 1

 

Level 2

 

Level 3

 

Total

 

Cash equivalents:

 

 

 

 

 

 

 

 

Money market funds

$

8,448

 

$

-

 

$

-

 

$

8,448

 

Total cash equivalents

$

8,448

 

$

-

 

$

-

 

$

8,448

 

Current marketable securities:

 

 

 

 

 

 

 

 

U.S. Treasury securities

$

-

 

$

7,942

 

$

-

 

$

7,942

 

Total current marketable securities

$

-

 

$

7,942

 

$

-

 

$

7,942

 

Total marketable securities and cash equivalents

$

8,448

 

$

7,942

 

$

-

 

$

16,390

 

Financial liabilities:

 

 

 

 

 

 

 

 

Loan Facility

$

-

 

$

-

 

$

42,984

 

$

42,984

 

Warrant liabilities

 

501

 

 

-

 

 

742

 

 

1,243

 

Non-qualified deferred compensation plan liability

 

-

 

 

3,973

 

 

-

 

 

3,973

 

Total financial liabilities

$

501

 

$

3,973

 

$

43,726

 

$

48,200

 

Financial assets:

 

 

 

 

 

 

 

 

Corporate-owned life insurance policies

$

-

 

$

3,116

 

$

-

 

$

3,116

 

Total financial assets

$

-

 

$

3,116

 

$

-

 

$

3,116

 

 

The following table presents the summary of changes in the fair value of the Company’s Level 3 financial instruments:

 

 

As of June 30, 2026

 

As of December 31, 2025

 

(in thousands)

Loan facility

 

Warrant liability

 

Loan facility

 

Warrant liability

 

Balance beginning of period

$

42,984

 

$

742

 

$

42,245

 

$

3,432

 

Extinguishment of Previous Credit Agreement

 

(42,984

)

 

-

 

 

-

 

 

-

 

Loan Facility fair value, at issuance

 

48,357

 

 

1,043

 

 

-

 

 

-

 

Reclassification of warrant liability to equity due to issuance

 

-

 

 

(1,290

)

 

-

 

 

-

 

Change in fair value in earnings

 

(409

)

 

384

 

 

1,322

 

 

(2,690

)

Change in fair value in other comprehensive loss

 

(1,289

)

 

-

 

 

(583

)

 

-

 

Balance end of period, at fair value

$

46,659

 

$

879

 

$

42,984

 

$

742

 

 

The Company’s Level 1 assets include money market instruments and are valued based upon observable market prices. The Company’s Level 1 liabilities included the Penny Warrant (as defined below) which was valued based upon observable market prices. Level 2 assets consist of U.S Treasury securities. Level 2 securities are valued based upon observable inputs that include reported trades, broker/dealer quotes, bids and offers. The corporate-owned life insurance contracts are recorded at cash surrender value, which approximates the fair value and is categorized as Level 2. Non-qualified deferred compensation plan liability is measured at fair value based on quoted prices of identical instruments to the investment vehicles selected by the participants, and is recorded as Level 2. There were no transfers between fair value measurement levels during the periods ended June 30, 2026 and December 31, 2025.

Loan Facility

The fair value of the loan facility was determined using a discounted cash flow method to value the initial term loan using a risk-free interest rate of 4.17% as of June 30, 2026. The valuation was performed based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy. The fair value of the loan facility is recorded in the Consolidated Balance Sheets. The fair value is estimated by the Company each reporting period and the change in the fair value is recorded in both earnings and other comprehensive income, depending on both the instrument's inherent credit risk and the market risk related to the debt valuation.

 

Warrant Liabilities

 

Perceptive Warrant

 

On the Closing Date, as defined in Note 6 to the Consolidated Financial Statements, the Company agreed to issue, subject to shareholder approval, a warrant to purchase up to 650,000 shares of the Company’s common stock (“Common Stock”), par value $0.0001 per share, at an exercise price set at the lower of two 10-day VWAPs: (i) the 10-day VWAP ending on the business day immediately prior to the Closing Date, which VWAP is $3.4019; or (ii) the 10-day VWAP ending on the business day immediately prior to the issuance date of the warrant. On June 3, 2026 (the “Shareholder Approval Date”), shareholders approved the issuance of the warrant and a warrant to purchase up to 650,000 shares of Common Stock was issued with an exercise price of $3.4019 (the “Perceptive Warrant”). The Perceptive Warrant is immediately exercisable for 500,000 shares of Common Stock, with an additional 150,000 shares of Common Stock that will vest and become exercisable if the Company closes on the Additional Commitment Amount.

 

The fair value of the Perceptive Warrant was determined based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy. The fair value of the Perceptive Warrant, which was reported within Warrant liabilities on the Closing Date and subsequently reclassified on the Shareholder Approval Date to Additional paid-in capital on the Consolidated Balance Sheets, was estimated by the Company based on the Black-Scholes option pricing model with the following key inputs as of the Shareholder Approval Date:

 

 

As of June 3, 2026

 

Price of common stock

$

4.16

 

Expected term

10.00 years

 

Expected volatility

 

37.51

%

Exercise price

$

3.4019

 

Risk-free interest rate

 

4.44

%

Expected dividends

 

0.00

%

 

Penny Warrant

 

On February 13, 2025, the Company issued a warrant to purchase 145,180 shares of Common Stock with an exercise price of $0.01 per share (the “Penny Warrant”). The Penny Warrant was issued in connection with the Previous Credit Agreement as defined in Note 6 of the Consolidated Financial Statements. On March 4, 2026, the Penny Warrant was exercised and 144,895 shares of Common Stock were issued.

 

The fair value of the Penny Warrant liability was determined based on quoted prices in active markets, which represents a Level 1 measurement within the fair value hierarchy. The fair value of the Penny Warrant liability, which was reported within Warrant liabilities on the Consolidated Balance Sheets, was estimated by the Company based on the closing price of the Common Stock as quoted on the Nasdaq Capital Market (“Nasdaq”) under the ticker code, “RCEL.”

 

$10.218 Warrant

 

On October 18, 2023, the Company issued a warrant to purchase 409,661 shares of Common Stock with an exercise price of $10.9847 per share as consideration for the Previous Credit Agreement as defined in Note 6 to the Consolidated Financial Statements. As a result of the issuance of Common Stock via a private placement on the ASX on August 12, 2025, the exercise price to purchase the Common Stock as provided in the warrant was adjusted to $10.218 (the “$10.218 Warrant”). The fair value of the $10.218 Warrant liability was determined based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy. The fair value of the $10.218 Warrant liability, which is reported within Warrant liabilities on the Consolidated Balance Sheets, is estimated by the Company based on the Black-Scholes option pricing model with the following key inputs:

 

 

As of

 

 

June 30, 2026

 

December 31, 2025

 

Price of common stock

$

4.13

 

$

3.45

 

Expected term

7.31 years

 

7.80 years

 

Expected volatility

 

66.80

%

 

68.94

%

Exercise price

$

10.2180

 

$

10.2180

 

Risk-free interest rate

 

4.27

%

 

3.97

%

Expected dividends

 

0.00

%

 

0.00

%